Vascular function in breast cancer survivors on aromatase inhibitors: a pilot study

[1]  A. Lerman,et al.  Endothelial function predicts 1-year adverse clinical outcome in patients hospitalized in the emergency department chest pain unit. , 2017, International journal of cardiology.

[2]  Amy M. Sitapati,et al.  NCCN Guidelines Insights: Breast Cancer, Version 1.2017. , 2017, Journal of the National Comprehensive Cancer Network : JNCCN.

[3]  S. Suissa,et al.  Cardiotoxicity of aromatase inhibitors and tamoxifen in postmenopausal women with breast cancer: a systematic review and meta-analysis of randomized controlled trials , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

[4]  D. Bluemke,et al.  Comparing Arterial Function Parameters for the Prediction of Coronary Heart Disease Events: The Multi-Ethnic Study of Atherosclerosis (MESA). , 2016, American journal of epidemiology.

[5]  P. Austin,et al.  The risk of myocardial infarction with aromatase inhibitors relative to tamoxifen in post-menopausal women with early stage breast cancer. , 2016, European journal of cancer.

[6]  S. Mak,et al.  Effects of estradiol on measurements of conduit artery endothelial function after ischemia and reperfusion in premenopausal women. , 2016, Canadian journal of physiology and pharmacology.

[7]  T. Whelan,et al.  Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years. , 2016, The New England journal of medicine.

[8]  T. Whelan,et al.  Competing risks of death in women treated with adjuvant aromatase inhibitors for early breast cancer on NCIC CTG MA.27 , 2016, Breast Cancer Research and Treatment.

[9]  A. Neugut,et al.  Cardiovascular Disease Mortality Among Breast Cancer Survivors , 2016, Epidemiology.

[10]  K. Liscum,et al.  The use of breast MRI in early-stage breast cancer: Findings after implementation of an institutional protocol at a county hospital. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  D. Yee,et al.  Arterial elasticity in testicular cancer survivors. , 2014 .

[12]  K. Fujisue,et al.  Endothelial function and cardiovascular events in chronic kidney disease. , 2014, International journal of cardiology.

[13]  Patrick Neven,et al.  Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up. , 2011, The Lancet. Oncology.

[14]  R. Kronmal,et al.  Association of small artery elasticity with incident cardiovascular disease in older adults: the multi-ethnic study of atherosclerosis. , 2011, American journal of epidemiology.

[15]  Jack Cuzick,et al.  Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial. , 2010, The Lancet. Oncology.

[16]  R. Rubinshtein,et al.  Assessment of endothelial function by non-invasive peripheral arterial tonometry predicts late cardiovascular adverse events. , 2010, European heart journal.

[17]  N. Koren-Morag,et al.  Long-term association of brachial artery flow-mediated vasodilation and cardiovascular events in middle-aged subjects with no apparent heart disease. , 2009, International journal of cardiology.

[18]  P. Lønning,et al.  Survival and safety of exemestane versus tamoxifen after 2–3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial , 2007, The Lancet.

[19]  J. Klijn,et al.  Decreased risk of stroke among 10-year survivors of breast cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  B. Lindgren,et al.  Reduced small artery but not large artery elasticity is an independent risk marker for cardiovascular events. , 2003, American journal of hypertension.

[21]  M. Mendelsohn,et al.  Protective effects of estrogen on the cardiovascular system. , 1999, The American journal of cardiology.

[22]  Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials , 2012 .

[23]  E. Winer,et al.  Risk of myocardial infarction, stroke, and fracture in a cohort of community-based breast cancer patients , 2011, Breast Cancer Research and Treatment.